IDEXX LABORATORIES INC /DE Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
IDEXX LABORATORIES INC /DE (IDXX) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $1.75 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-02-16.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2023-02-16
- IDEXX LABORATORIES INC /DE unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2020 was $1.75M, a 535.87% increase from fiscal 2019.
- IDEXX LABORATORIES INC /DE unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2019 was $276.00K.
- IDEXX LABORATORIES INC /DE unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2013 was $8.00K, a 97.24% decline from fiscal 2012.
- IDEXX LABORATORIES INC /DE unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2012 was $290.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2020-12-31 | $1.75M 10-K · filed 2023-02-16 |
| 2019-12-31 | $276.00K 10-K · filed 2022-02-16 |
| 2013-12-31 | $8.00K 10-K · filed 2014-02-18 |
| 2012-12-31 | $290.00K 10-K · filed 2014-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |